Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs.
costs
cystic fibrosis
metropolitan
regional
resistant microbiota
telehealth
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
received:
06
08
2023
accepted:
02
10
2023
medline:
27
10
2023
pubmed:
27
10
2023
entrez:
27
10
2023
Statut:
aheadofprint
Résumé
The experience of outpatient care may differ for select patient groups. This prospective study evaluates the adult patient experience of multidisciplinary outpatient cystic fibrosis (CF) care with videoconferencing through telehealth compared with face-to-face care the year prior. People with CF without a lung transplant were recruited. Patient-reported outcomes were obtained at commencement and 12 months into the study, reflecting both their face-to-face and telehealth through videoconferencing experience, respectively. Three patient cohorts were analysed: (i) participants with a regional residence, (ii) participants with a nonregional including metropolitan residence and (iii) participants with colonised multiresistant microbiota. Seventy-four patients were enrolled in the study (mean age, 37 ± 11 years; 50% male; mean forced expiratory volume in the first second of expiration, 60% [standard deviation, 23]) between February 2020 and May 2021. No differences between models were observed in the participants' rating of the health care team, general and mental health rating, and their confidence in handling treatment plans at home. No between-group differences in the Cystic Fibrosis Questionnaire - Revised (CFQ-R) were observed. Travel duration and the cost of attending a clinic was significantly reduced, particularly for the regional group (4 h, AU$108 per clinic; P < 0.05). A total of 93% respondents preferred to continue with a hybrid approach. In this pilot study, participants' experience of care and quality of life were no different with face-to-face and virtual care between the groups. Time and cost-savings, particularly for patients living in regional areas, were observed. Most participants preferred to continue with a hybrid model for outpatient care.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
The experience of outpatient care may differ for select patient groups. This prospective study evaluates the adult patient experience of multidisciplinary outpatient cystic fibrosis (CF) care with videoconferencing through telehealth compared with face-to-face care the year prior.
METHODS
METHODS
People with CF without a lung transplant were recruited. Patient-reported outcomes were obtained at commencement and 12 months into the study, reflecting both their face-to-face and telehealth through videoconferencing experience, respectively. Three patient cohorts were analysed: (i) participants with a regional residence, (ii) participants with a nonregional including metropolitan residence and (iii) participants with colonised multiresistant microbiota.
RESULTS
RESULTS
Seventy-four patients were enrolled in the study (mean age, 37 ± 11 years; 50% male; mean forced expiratory volume in the first second of expiration, 60% [standard deviation, 23]) between February 2020 and May 2021. No differences between models were observed in the participants' rating of the health care team, general and mental health rating, and their confidence in handling treatment plans at home. No between-group differences in the Cystic Fibrosis Questionnaire - Revised (CFQ-R) were observed. Travel duration and the cost of attending a clinic was significantly reduced, particularly for the regional group (4 h, AU$108 per clinic; P < 0.05). A total of 93% respondents preferred to continue with a hybrid approach.
CONCLUSION
CONCLUSIONS
In this pilot study, participants' experience of care and quality of life were no different with face-to-face and virtual care between the groups. Time and cost-savings, particularly for patients living in regional areas, were observed. Most participants preferred to continue with a hybrid model for outpatient care.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Sydney Local Health District Innovation Award
Informations de copyright
© 2023 Royal Australasian College of Physicians.
Références
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med 2020; 8: 65-124.
Mogayzel PJ Jr, Dunitz J, Marrow LC, Hazle LA. Improving chronic care delivery and outcomes: the impact of the cystic fibrosis care center network. BMJ Qual Saf 2014; 23: i3-i8.
Conway S, Balfour-Lynn IM, De Rijcke K, Drevinek P, Foweraker J, Havermans T et al. European cystic fibrosis society standards of care: framework for the cystic fibrosis centre. J Cyst Fibros 2014; 13: S3-S22.
Wood J, Jenkins S, Mulrennan S, Hill K. The impact of cystic fibrosis on work attendance and performance in adults living in rural and remote Western Australia. J Cyst Fibros 2017; 16: e1-e2.
Wood J, Mulrennan S, Hill K, Cecins N, Morey S, Jenkins S. Telehealth clinics increase access to care for adults with cystic fibrosis living in rural and remote Western Australia. J Telemed Telecare 2017; 23: 673-679.
Yan J, Kevat A, Martinez E, Teese N, Johnson K, Ranganathan S et al. Investigating transmission of Mycobacterium abscessus amongst children in an Australian cystic fibrosis centre. J Cyst Fibros 2019; 19: 219-224.
McDowell A, Mahenthiralingam E, Dunbar KE, Moore JE, Crowe M, Elborn JS. Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. J Med Microbiol 2004; 53: 663-668.
Stockwell RE, Wood ME, Ballard E, Moore V, Wainwright CE, Bell SC. Current infection control practices used in Australian and New Zealand cystic fibrosis centers. BMC Pulm Med 2020; 20: 16.
Infection Prevention and Control Practice Handbook. Principles for NSW public health organisations. Clinical Excellence Commission; 2020.
Prickett MH, Flume PA, Sabadosa KA, Tran QT, Marshall BC. Telehealth and CFTR modulators: accelerating innovative models of cystic fibrosis care. J Cyst Fibros 2023; 22: 9-16.
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208.
Young DC, Autry E, Zobell JT, Kormelink L, Homa K, Sabadosa KA et al. Patients and families experience with pharmacist care at cystic fibrosis foundation accredited clinics. Pediatr Pulmonol 2019; 54: 1216-1224.
Ronit A, Gelpi M, Argentiero J, Mathiesen I, Nielsen SD, Pressler T et al. Electronic applications for the CFQ-R scoring. Respir Res 2017; 18: 108.
Morgan DG, Kosteniuk J, Stewart N, O'Connell ME, Karunanayake C, Beever R. The telehealth satisfaction scale: reliability, validity, and satisfaction with telehealth in a rural memory clinic population. Telemed J E Health 2014; 20: 997-1003.
Boling W, Macrina DM, Clancy JP. The Caregiver Quality of Life Cystic Fibrosis (CQOLCF) scale: modification and validation of an instrument to measure quality of life in cystic fibrosis family caregivers. Qual Life Res 2003; 12: 1119-1126.
Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM et al. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros 2021; 26: S69.
Shanthikumar S, Moore E, Corda J, Reardon N, Louey S, Frayman K et al. Patient and family perspectives regarding the use of telehealth for cystic fibrosis care. Pediatr Pulmonol 2021; 56: 811-813.
Lang RL, Wilson C, Stockton K, Russell T, Johnston LM. CyFiT telehealth: protocol for a randomised controlled trial of an online outpatient physiotherapy service for children with cystic fibrosis. BMC Pulm Med 2019; 19: 21.
Ahern S, Salimi, FE, Caruso M, Ruseckaite R, Bell S, Burke N et al. The Australian Cystic Fibrosis Data Registry. Annual Report 2020; 2021:56.